Alagebrium chloride

N/A

Report date: 2022/08/02 20:00:39
NME

Base Information

Drug NameAlagebrium chloride
Drug Alias NameAlagebrium chloridum阿拉氯胺阿拉氯铵ALT-711
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycosylation end product-specific receptor antagonists
TargetsAdvanced glycosylation end product-specific receptor
Therapy Area/IndicationsHealthy AgingDiabetes Mellitus, Type 1Hypertension +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsDenmark +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSynvista Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRadboud University Medical CenterCardiovascular Clinical Studies LlcSynvista Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHealthy AgingDiabetes Mellitus, Type 1Hypertension +[11] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG